Mediplus

Non-Invasive Bladder Analysis For Men

Press Releases

Clinical Proof the Mediplus CT3000 is effective at predicting the future!
Sep-Oct 2007

London’s Pelvic Floor Centre chooses the Mediplus CT3000. Sep-Oct 2007

World’s first National Technology Adoption Hub for Healthcare launches in Manchester. 28th September 2007

The Centre for Evidence-based Purchasing reports significant potential and promising results of the Mediplus CT3000 cuff machine for diagnosis of bladder outlet obstruction. August 2007

Predicting the Outcome of Prostatectomy Using Noninvasive Bladder Pressure and Urine Flow Measurements. 22nd March 2007

United Lincolnshire Hospitals NHS Trust sees the benefits of using The CT3000. Jan-Feb 2007

Mediplus CT3000 Cuff Machine has been submitted for evaluation by The National Coordinating Centre for Health Technology Assessment (NCCHTA) 23rd September 2005

Mediplus Launch the worlds first non-invasive method of measuring bladder pressure in men. 21st March 2005

Press Release

World’s first National Technology Adoption Hub for Healthcare launches in Manchester.
28th September 2007

The world’s first National Technology Adoption Hub for healthcare has been unveiled in Manchester.

The Hub is aimed at helping the NHS better implement new cost-effective, life-saving technologies.  Hosted by the Central Manchester and Manchester Children’s University Hospital Trust, it will take up 15 innovative medical technologies over the next three years, and examine how they can be put into practice in the quickest, most effective way to improve NHS productivity.

Margaret Parton, CEO of the National Technology Hub, unveiled the Hub to over 150 leading clinicians, NHS managers, academics and representatives from the medical technology industry.   The Hub is supported by Professor Lord Ara Darzi, who is currently leading a whole-sale review of the NHS: “Schemes such as the National Technology Adoption Hub shows the extent of the innovation and development within the NHS.  It is encouraging to see the NHS continually striving to find the best standards of care, using the latest available techniques, for its patients.”

Margaret Parton also confirmed the Hub’s commitment to aiding the roll-out of crucial innovations in medical technology:  “It is vital that new life-saving, cost-effective technologies are adopted as quickly as possible through the NHS.  The National Technology Adoption Hub will streamline and speed up the process for the benefit of patients, and the NHS as a whole.” 

The CT3000 Non-Invasive Bladder Analysis for Men manufactured by Mediplus was one of the first technologies to be reviewed and unveiled at the launch event in Manchester’s Whitworth Art Gallery: Only products that are proven cost-effective measures that have delivered real benefits to trusts and patients where implemented, and could transform the standards of care up and down the country.

James Urie from Mediplus commented: “The CT3000 is an effective, non-invasive procedure that provides an accurate diagnosis, saving the NHS – and patients – time, inconvenience and money.” 

The Hub will work with host trusts to review adoption of the technologies and gain greater understanding of the challenges and benefits of adoption at a component level, a local systems and whole systems level, across the NHS and beyond the NHS to social services and employment.

  • The NHS National Adoption Technology Hub is funded by the National Innovation Centre, NHS North West, North West Development Agency and TrusTECH

Get Adobe Reader
Mediplus CT3000, non-invasive bladder analysis for men, prostate analysis, bladder outlet obstruction, Pressure flow studies, cuff machine, Newcastle cuff test, Transurethral Prostatectomy, Radical Transurethral Prostatectomy, Lower urinary tract symptoms, Cystometry, Urine, Urinary flow test, Transurethral resection prostate, Bladder contractility.Website Design.